Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study
K.P. Perrett, J. Mcvernon, Peter Richmond, H. Marshall, M. Nissen, A. August, S. Percell, D. Toneatto, T. Nolan
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Immune responses to a recombinant, four-component, meningococcal serogroup B vaccine (4CMenB) in adolescents: A phase III, randomized, multicentre, lot-to-lot consistency study'. Together they form a unique fingerprint.